Like_老虎社区_美港股上老虎

4a650fb1
2021-09-27

Exscientia Sets IPO at 13.1 Million ADSs; Sees Pricing at $20-$22 Each

Exscientia PLC on Monday said it plans to sell nearly 13.1 million American depositary shares at bet

Exscientia Sets IPO at 13.1 Million ADSs; Sees Pricing at $20-$22 Each

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":866885700,"tweetId":"866885700","gmtCreate":1632753549600,"gmtModify":1632798073326,"author":{"id":4087797722131370,"authorId":4087797722131370,"authorIdStr":"4087797722131370","name":"4a650fb1","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like</p></body></html>","htmlText":"<html><head></head><body><p>Like</p></body></html>","text":"Like","highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/866885700","repostId":1104751854,"repostType":4,"repost":{"id":"1104751854","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1632753249,"share":"https://www.laohu8.com/m/news/1104751854?lang=&edition=full","pubTime":"2021-09-27 22:34","market":"us","language":"en","title":"Exscientia Sets IPO at 13.1 Million ADSs; Sees Pricing at $20-$22 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1104751854","media":"Dow Jones","summary":"Exscientia PLC on Monday said it plans to sell nearly 13.1 million American depositary shares at bet","content":"<p>Exscientia PLC on Monday said it plans to sell nearly 13.1 million American depositary shares at between $20 and $22 apiece in its initial public offering.</p>\n<p>At the $21 midpoint of that range, the Oxford, U.K., clinical-stage pharmatech company said it expects net proceeds of about $249.2 million, or roughly $287.6 million if the underwriters exercise an option to buy an additional 1.96 million ADSs.</p>\n<p>Exscientia said it also expects to net about $151.3 million from concurrent private placements of $125 million with an affiliate of SoftBank Group Corp. and $35 million with the Bill &amp; Melinda Gates Foundation.</p>\n<p>Exscientia, which is using artificial intelligence to design patient-based drugs, said it believes the proceeds from the IPO and private placements, coupled with its existing resources, will be sufficient to fund its operations and capital-spending needs for at least a year.</p>\n<p>Each Exscientia represents one ordinary share. In a filing with the U.S. Securities and Exchange Commission, Exscientia said it would have about 119.9 million shares outstanding after the IPO and private placements, assuming exercise of the overallotment option, for a market capitalization topping $2.5 billion at the $21-a-share pricing midpoint.</p>\n<p>Exscientia said it has applied to list its ADSs on the Nasdaq Global Select Market under the symbol EXAI.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Exscientia Sets IPO at 13.1 Million ADSs; Sees Pricing at $20-$22 Each </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExscientia Sets IPO at 13.1 Million ADSs; Sees Pricing at $20-$22 Each \n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-09-27 22:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Exscientia PLC on Monday said it plans to sell nearly 13.1 million American depositary shares at between $20 and $22 apiece in its initial public offering.</p>\n<p>At the $21 midpoint of that range, the Oxford, U.K., clinical-stage pharmatech company said it expects net proceeds of about $249.2 million, or roughly $287.6 million if the underwriters exercise an option to buy an additional 1.96 million ADSs.</p>\n<p>Exscientia said it also expects to net about $151.3 million from concurrent private placements of $125 million with an affiliate of SoftBank Group Corp. and $35 million with the Bill &amp; Melinda Gates Foundation.</p>\n<p>Exscientia, which is using artificial intelligence to design patient-based drugs, said it believes the proceeds from the IPO and private placements, coupled with its existing resources, will be sufficient to fund its operations and capital-spending needs for at least a year.</p>\n<p>Each Exscientia represents one ordinary share. In a filing with the U.S. Securities and Exchange Commission, Exscientia said it would have about 119.9 million shares outstanding after the IPO and private placements, assuming exercise of the overallotment option, for a market capitalization topping $2.5 billion at the $21-a-share pricing midpoint.</p>\n<p>Exscientia said it has applied to list its ADSs on the Nasdaq Global Select Market under the symbol EXAI.</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EXAI":"Exscientia plc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104751854","content_text":"Exscientia PLC on Monday said it plans to sell nearly 13.1 million American depositary shares at between $20 and $22 apiece in its initial public offering.\nAt the $21 midpoint of that range, the Oxford, U.K., clinical-stage pharmatech company said it expects net proceeds of about $249.2 million, or roughly $287.6 million if the underwriters exercise an option to buy an additional 1.96 million ADSs.\nExscientia said it also expects to net about $151.3 million from concurrent private placements of $125 million with an affiliate of SoftBank Group Corp. and $35 million with the Bill & Melinda Gates Foundation.\nExscientia, which is using artificial intelligence to design patient-based drugs, said it believes the proceeds from the IPO and private placements, coupled with its existing resources, will be sufficient to fund its operations and capital-spending needs for at least a year.\nEach Exscientia represents one ordinary share. In a filing with the U.S. Securities and Exchange Commission, Exscientia said it would have about 119.9 million shares outstanding after the IPO and private placements, assuming exercise of the overallotment option, for a market capitalization topping $2.5 billion at the $21-a-share pricing midpoint.\nExscientia said it has applied to list its ADSs on the Nasdaq Global Select Market under the symbol EXAI.","news_type":1},"isVote":1,"tweetType":1,"viewCount":343,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Exscientia Sets IPO at 13.1 Million ADSs; Sees Pricing at $20-$22 Each

评论（2）

热议股票